How HPLC Purity Is Measured on a Peptide Lot

The separation, in plain terms

Reversed-phase high performance liquid chromatography separates the components of a sample by how strongly each one interacts with a non-polar stationary phase packed into a column. A small volume of dissolved sample is injected into a stream of solvent. Water-rich mobile phase carries polar species through quickly; as the proportion of organic solvent — usually acetonitrile — is increased over the course of the run, progressively more hydrophobic species release from the packing and elute.

For a synthetic peptide this is an effective separation because the most likely process-related impurities are structurally close to the target: chains missing one residue, chains carrying a protecting group that was not fully removed, oxidised methionine, deamidated asparagine or glutamine. Those species differ from the intended sequence by a small change in hydrophobicity, which reversed-phase chromatography is sensitive to. They emerge as separate peaks slightly before or after the main peak.

A detector sits at the column outlet. For peptides this is normally a UV detector set near 214 nm, where the peptide bond itself absorbs, sometimes with a second channel at 280 nm where tryptophan and tyrosine absorb. The output is a chromatogram: detector response plotted against time.

Where the percentage comes from

Integration software draws a baseline under the chromatogram and calculates the area of each resolved peak. The reported purity is the area of the main peak divided by the total integrated area of all peaks, expressed as a percentage. This is why the value is properly written as area-percent at a stated wavelength, not simply as purity.

That definition carries a consequence that is easy to miss. Area-percent is a relative measure among things the detector could see. Anything that does not absorb meaningfully at the detection wavelength contributes no area and therefore does not reduce the percentage. Residual water from lyophilization, counter-ions such as trifluoroacetate or acetate left from purification, and inorganic salts are all common in a lyophilized peptide powder and all effectively invisible to a UV chromatogram.

A vial can therefore hold material that is 99 percent pure by HPLC area and still contain a substantial mass fraction that is not peptide. Peptide content — the actual proportion of the powder that is the peptide itself — is a separate determination, typically by amino acid analysis or nitrogen determination, and it is a different number from chromatographic purity. When both appear on a report they should be read as answers to two different questions.

Conditions change the number

An area-percent figure is only interpretable alongside the method that produced it. Column chemistry and particle size, column temperature, gradient slope, run length, buffer additive, injection mass and detection wavelength all shift how well neighbouring species resolve. A shallow gradient over a long run on a small-particle column will separate a closely eluting deletion impurity into its own peak. A steep gradient may bury that same impurity under the shoulder of the main peak, where integration counts its area as part of the target.

The result is that two laboratories can analyse the same powder and report different purity values without either being dishonest. This is also why a report that states a purity figure and nothing about the method is of limited use. A useful report names the column, the mobile phase composition, the gradient, the wavelength and the run time, and ideally includes the chromatogram itself so a reader can see the baseline and the peak shape rather than trusting a single printed number.

• Detection wavelength — determines which impurities are visible at all.
• Gradient and run time — determine whether close-eluting species resolve or merge.
• Column chemistry, particle size and temperature — determine peak width and resolution.
• Integration parameters — determine where the baseline is drawn and which small peaks are counted.

What the chromatogram shows that the number does not

Reading the trace rather than the summary answers questions the percentage cannot. A main peak that is symmetrical and narrow suggests a well-resolved single species. A peak with a pronounced shoulder or a tail suggests co-elution, and the reported purity for that peak may be aggregating more than one component. A drifting or elevated baseline can indicate a poorly equilibrated column or a sample matrix effect, both of which affect integration.

The distribution of impurities matters as well as their total. Ten small peaks each contributing a fraction of a percent is a different profile from one impurity contributing the same total area on its own, even though both give the same headline purity. The first is often characteristic of ordinary synthesis and cleavage byproducts; the second warrants identification.

Finally, an area-percent purity says nothing about which species the impurities are. Chromatography sorts by retention behaviour, not identity. Assigning a name to an impurity peak requires a mass-selective detector or fraction collection followed by separate analysis.

What HPLC purity does not measure

Purity by HPLC is a compositional measure of UV-absorbing species, and it should not be extended past that.

It does not measure biological activity. Two lots with identical chromatographic purity can behave differently in an assay because of differences in counter-ion, water content, aggregation state, or handling history. It does not confirm identity — a species can co-elute with the target and be counted as target. Identity confirmation requires mass spectrometry, and full sequence confirmation requires sequencing or tandem MS fragmentation. It does not detect endotoxin, which requires an LAL or recombinant Factor C assay. It is not a sterility test. And it describes the sample as it existed on the day of injection, not the material after shipping and storage.

Practical reading

When a purity figure appears on a certificate, treat it as one measurement among several rather than a grade. Check that the wavelength and method are stated. Check whether the chromatogram is included and whether the main peak is clean. Check whether identity was confirmed separately by mass. Check whether peptide content is reported, and note the difference if it is. And check that the report names the specific lot code printed on the vial — a purity figure attached to a catalog entry rather than a lot describes a different batch of material than the one in front of you.